Search clinical trials for: Cytomegalovirus keratouveitis

Total 526 results

The George Washington University Biostatistics...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) (CMV)

Congenital Cytomegalovirus Infection | Maternal Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Cytomegalovirus Infection

United States
Chimerix

Completed

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

Double-stranded DNA Virus

United States
Institut Pasteur

Completed

Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV (INFECSMELL)

Congenital Cytomegalovirus Infection

France
Kuifang Du
Beijing Tongren Hospital

Completed

Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis

Cytomegalovirus Retinitis

China
Chimerix

Completed

Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients

Cytomegalovirus Infection

United States
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

Kidney Transplant Infection | Cytomegalovirus Disease

United States
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease (SUSTAIN)

Cytomegalovirus Disease

United States
Shire

Completed

Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Cytomegalovirus Infections

United States, Canada, United Kingdom, Germany, France, Belgium, Italy, Spain, Sweden
Shire

Completed

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

Cytomegalovirus Infections

United States
Shire

Completed

Study of SHP620 (Maribavir) in Healthy Adults

Cytomegalovirus (CMV)

United States
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Completed

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (CONCERT 2)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Cytomegalovirus Infection

United Kingdom, United States
Shire

Completed

Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

Cytomegalovirus (CMV)

United States
Shahid Beheshti University of Medical Sciences

Completed

Comparison of Safety and Efficacy of de Novo Everolimus

Cytomegalovirus Infections

Iran, Islamic Republic of
Shire

Completed

Maribavir for Prevention of CMV After Stem Cell Transplants

Cytomegalovirus Infection

United States
University of Lausanne Hospitals

Completed

Cell-mediated Immunity for Prevention of CMV Disease

Cytomegalovirus Infections

Switzerland
GlaxoSmithKline

Completed

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus

Finland, United States, Mexico
St George's, University of London
University College, London; University of Cambridge; Kingston University; CMV Action

Completed

Reducing Acquisition of CMV Through Antenatal Education (RACEFIT)

Cytomegalovirus Congenital

United Kingdom
National Cancer Institute (NCI)

Completed

The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis

AIDS

United States
Karolinska Institutet
Karolinska University Hospital

Completed

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Glioblastoma Multiforme | Cytomegalovirus Infection

Sweden
Maimónides Biomedical Research Institute of Córdoba

Completed

Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.

Kidney Transplant Infection

Spain
Gary Archer Ph.D.

Completed

Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma (ATTAC-P)

Glioblastoma | Malignant Glioma | Pediatric Brain Tumor | Medulloblastoma Recurrent | Pediatric Glioblastoma Multiforme | Pediatric Brain Tumor, Recurrent

United States
ModernaTX, Inc.

Completed

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

Cytomegalovirus Infection

United States
Memorial Sloan Kettering Cancer Center
Atara Biotherapeutics

Completed

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Cytomegalovirus

United States
University of Erlangen-Nürnberg Medical School
German Research Foundation; Charite University, Berlin, Germany; Ludwig-Maximilians... and other collaborators

Completed

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Patients Undergoing Allogeneic Stem Cell Transplantation

Germany
Fundación para la Investigación del Hospital Clínico...

Completed

Pre-engraftment Cytomegalovirus DNAemia

CMV DNAemia Pre-engraftment

Spain
Kirby Institute
National Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare and other collaborators

Withdrawn

Inflammation and Co-Infections in D²EFT (i2-D²EFT)

Cytomegalovirus Infections | Human Papilloma Virus | HIV-infection/Aids | Human Herpesvirus 4 Infections | Human Herpesvirus 8 Infection
University Hospital, Grenoble

Completed

Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients (Quantiferon)

Hemodialysis | Kidney Transplant Infection | Cytomegalovirus Infections | Quantiferon-CMV

France
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation

Completed

PREDICT Cytomegalovirus (CMV) (PREDICT CMV)

Lung Transplant

United States, Canada
University of California, San Francisco
Roche Pharma AG

Completed

Valganciclovir to Reduce T Cell Activation in HIV Infection

HIV Infections | Cytomegalovirus Infections

United States
Medy-Tox

Completed

Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

Hyperhidrosis Primary Focal Axilla

Korea, Republic of
GlaxoSmithKline

Completed

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

Cytomegalovirus Infections | Infections, Cytomegalovirus

Belgium
University of Alabama at Birmingham

Completed

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Cytomegalovirus Infections

United States
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)

Lung Transplant; Complications
VBI Vaccines Inc.
Clinical Trial Data Services, LLC

Completed

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

Cytomegalovirus Infections

Canada
Yae-Jean Kim
Miltenyi Biotec B.V. & Co. KG

Withdrawn

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Cytomegalovirus Infections

Korea, Republic of
M.D. Anderson Cancer Center
Miltenyi Biotec B.V. & Co. KG

Completed

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Lymphoma | Leukemia

United States
Hoffmann-La Roche

Completed

A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation

Cytomegalovirus Infections

Germany, Austria
Memorial Sloan Kettering Cancer Center

Completed

Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants

Cytomegalovirus Infections

United States
Peking University People's Hospital

Completed

Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation

CMV Infection

China
Fundación de investigación HM
Merck Sharp & Dohme LLC

Unknown

Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy (CMV-ICU)

CMV
Meenakshi Ammal Dental College and Hospital

Unknown

Evaluation of Inflammatory Markers and Periodontal Viruses on Periodontitis Patients With CAD

Coronary Artery Disease | Periodontitis

India
Asan Medical Center

Completed

Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis (ACE-UC)

Ulcerative Colitis | Cytomegalovirus Infections | Disease Exacerbation

Korea, Republic of
GlaxoSmithKline

Completed

Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine

Infections, Cytomegalovirus

Belgium
Peking University People's Hospital

Unknown

Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection

Cytomegalovirus Infections
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance (GANCIMVEAR)

Congenital Cytomegalovirus (CMV)

France
Shaare Zedek Medical Center

Unknown

The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection

Pregnant Women | Cytomegalovirus Infections

Israel
University Hospital, Limoges

Terminated

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test. (QUANTIC-R+)

Renal Transplant Recipient | Immunized Against the Cytomegalovirus

France
University Hospital, Limoges

Completed

A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. (ORPHAVIC)

Transplant Recipients With CMV Infection

France

Search clinical trials for: Cytomegalovirus keratouveitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations